|
Volumn 20, Issue 10, 2014, Pages 1090-1091
|
Reply: The BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIM PROTEIN;
IMATINIB;
APOPTOSIS REGULATORY PROTEIN;
MEMBRANE PROTEIN;
ONCOPROTEIN;
PROTEIN KINASE INHIBITOR;
CHINESE;
CHRONIC MYELOID LEUKEMIA;
CLINICAL FEATURE;
GENE DELETION;
HETEROZYGOTE;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
PROTEIN POLYMORPHISM;
TREATMENT RESPONSE;
WILD TYPE;
APOPTOSIS;
DRUG EFFECTS;
DRUG RESISTANCE;
FEMALE;
GENETIC POLYMORPHISM;
GENETICS;
LUNG TUMOR;
MALE;
NON SMALL CELL LUNG CANCER;
APOPTOSIS;
APOPTOSIS REGULATORY PROTEINS;
CARCINOMA, NON-SMALL-CELL LUNG;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
LUNG NEOPLASMS;
MALE;
MEMBRANE PROTEINS;
POLYMORPHISM, GENETIC;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS;
SEQUENCE DELETION;
|
EID: 84921960257
PISSN: 10788956
EISSN: 1546170X
Source Type: Journal
DOI: 10.1038/nm.3652 Document Type: Letter |
Times cited : (6)
|
References (9)
|